Research output per year
Research output per year
Geoffrey Banda*, Cecilia Wanjala, Veronica Manduku, Dinar Kale
Research output: Chapter in Book/Report/Conference proceeding › Chapter
This chapter argues that the recent international support for expanding vaccine production in African countries offers local policymakers and industrialists an opportunity that should be seized, to transition local manufacturing capabilities to produce biologics. Biologics offer a broader portfolio of cancer therapies. Biologics such as monoclonal antibodies represent an incremental innovation for vaccine manufacturers, with lower learning and transition costs than those that would be faced by manufacturers of chemical drugs seeking to move into biologics. However, biologics production in Africa is not only a technological project, it is also political and economic, feeding into geo-politics debates.
Original language | English |
---|---|
Title of host publication | Cancer Care in Pandemic Times |
Subtitle of host publication | Building Inclusive Local Health Security in Africa and India |
Editors | Geoffrey Banda, Maureen Mackintosh, Mercy Karimi Njeru, Fortunata Songora Makene, Smita Srinivas |
Publisher | Palgrave Macmillan |
Chapter | 10 |
Pages | 215-239 |
Number of pages | 25 |
Edition | 1 |
ISBN (Electronic) | 9783031441233 |
ISBN (Print) | 9783031441226, 9783031441257 |
DOIs | |
Publication status | Published - 11 Jan 2024 |
Name | International Political Economy Series |
---|---|
Volume | Part F2092 |
ISSN (Print) | 2662-2483 |
ISSN (Electronic) | 2662-2491 |
Research output: Chapter in Book/Report/Conference proceeding › Chapter
Research output: Book/Report › Book
Research output: Chapter in Book/Report/Conference proceeding › Chapter